trending Market Intelligence /marketintelligence/en/news-insights/trending/822PVCiEABF4rTA9KUTA3w2 content esgSubNav
In This List

Amryt Pharma names chief commercial officer

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Amryt Pharma names chief commercial officer

Amryt Pharma PLC appointed David Allmond chief commercial officer in a nonboard capacity, effective April 3.

Allmond replaces Michele Bellandi, who has left the company.

Allmond was president of Europe, the Middle East and Africa at Aegerion Pharmaceuticals Inc. His previous roles include corporate vice president of global marketing for Celgene Corp. and director of sales and marketing effectiveness at Amgen Ltd.